BAT Says Potential COVID-19 Vaccine Using Tobacco Leaves Ready For Human Trials
World’s No.2 cigarette company British American Tobacco said it was ready to test its potential COVID-19 vaccine using proteins from tobacco leaves on humans, after it generated a positive immune response in pre-clinical trials.
The maker of Lucky Strike cigarette said once it gets approval from the US Food and Drug administration (FDA) for the vaccine, it would progress to Phase 1 trials or testing on humans.
The company raised eyebrows in April when it said it was developing a COVID-19 vaccine from tobacco leaves and could produce 1 million to 3 million doses per week if it got the support of government agencies and the right manufacturers.
ESM
Related news
France kicks off bird flu vaccination despite trade backlash risk
France began vaccinating ducks against bird flu on Monday to…
Read more >The durable and transparent packaging is the winner – results on the soup paste dry pasta Product sample
We asked the reviewers during the soup paste dry pasta…
Read more >Magazine: László Krisán: “Everyone has their share of responsibility in crisis management”
Our magazine asked László Krisán, the CEO of KAVOSZ Zrt.…
Read more >Related news
In 2023, SPAR realized a turnover of over HUF 1 billion
SPAR Hungary achieved a turnover of HUF 1,023.2 billion in…
Read more >Primark’s first domestic store will open in a month
Primark will open its doors at 10 a.m. on May…
Read more >Heineken achieved strong volume growth in the first quarter
Heineken, the world’s second largest beer producer, achieved a 4.7%…
Read more >